Blood Advances (@bloodadvances) 's Twitter Profile
Blood Advances

@bloodadvances

Peer-reviewed journal of @ASH_hematology publishing original articles describing basic laboratory, translational, and clinical investigations in hematology.

ID: 732570175162179585

linkhttp://www.bloodadvances.org calendar_today17-05-2016 13:55:15

6,6K Tweet

32,32K Takipçi

133 Takip Edilen

Blood Advances (@bloodadvances) 's Twitter Profile Photo
Blood Advances
@bloodadvances

7 months ago

In this retrospective analysis, siltuximab effectively treated CRS and ICANS with an objective response rate of 75% and 60%, respectively. ow.ly/kCvt50UGXHm #lymphoidneoplasia #transplantation

In this retrospective analysis, siltuximab effectively treated CRS and ICANS with an objective response rate of 75% and 60%, respectively. ow.ly/kCvt50UGXHm #lymphoidneoplasia #transplantation